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Endothelial function in pre-pubertal children at risk
of developing cardiomyopathy: a new frontier
Aline Cristina Tavares,I Edimar Alcides Bocchi,I Guilherme Veiga Guimara˜esI,II
IHospital das Clı´nicas da Faculdade de Medicina da Universidade de Sa˜o Paulo, Heart Institute (InCor), Sa˜o Paulo/SP, Brazil. IIUniversidade de Sa˜o Paulo,
Laboratory of Physical Activity and Health (LAtiS), Sport Practice Center, Sa˜o Paulo/SP, Brazil.
Although it is known that obesity, diabetes, and Kawasaki’s disease play important roles in systemic inflammation
and in the development of both endothelial dysfunction and cardiomyopathy, there is a lack of data regarding the
endothelial function of pre-pubertal children suffering from cardiomyopathy. In this study, we performed a
systematic review of the literature on pre-pubertal children at risk of developing cardiomyopathy to assess the
endothelial function of pre-pubertal children at risk of developing cardiomyopathy. We searched the published
literature indexed in PubMed, Bireme and SciELO using the keywords ‘endothelial’, ‘children’, ‘pediatric’ and
‘infant’ and then compiled a systematic review. The end points were age, the pubertal stage, sex differences, the
method used for the endothelial evaluation and the endothelial values themselves. No studies on children with
cardiomyopathy were found. Only 11 papers were selected for our complete analysis, where these included reports
on the flow-mediated percentage dilatation, the values of which were 9.80¡1.80, 5.90¡1.29, 4.50¡0.70, and
7.10¡1.27 for healthy, obese, diabetic and pre-pubertal children with Kawasaki’s disease, respectively. There was
no significant difference in the dilatation, independent of the endothelium, either among the groups or between
the genders for both of the measurements in children; similar results have been found in adolescents and adults.
The endothelial function in cardiomyopathic children remains unclear because of the lack of data; nevertheless, the
known dysfunctions in children with obesity, type 1 diabetes and Kawasaki’s disease may influence the severity of
the cardiovascular symptoms, the prognosis, and the mortality rate. The results of this study encourage future
research into the consequences of endothelial dysfunction in pre-pubertal children.
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INTRODUCTION
There are similarities between children and adults suffer-
ing from heart failure (HF), such as the preferred pharma-
cological treatment (1), the use of pace-makers and heart
transplants (2,3), the inability of the patient to reach the
predicted heart rate for the patient’s age during cardiopul-
monary exercise testing (4,5), and the ergoespirometric
response under similar clinical conditions (5). In adults,
endothelial dysfunction is related to the development of
diastolic dysfunction (6,7), Chagas disease, left ventricular
hypertrophy (8), ischemic cardiomyopathy, HF (8,9), obesity,
type 1 diabetes, hyperlipidemia, arterial hypertension (10),
peripheral arterial disease, chronic kidney disease (11) and
atherosclerosis (12) because the dysfunction predisposes the
vasculature to vasoconstriction, leukocyte adherence, platelet
activation, and vascular inflammation (13). Nevertheless,
there is a lack of data regarding endothelial function in
children with cardiomyopathy.
The severity of endothelial dysfunction is related to the
cardiovascular risk (14), the severity of cardiovascular
symptoms (15), and the inability to exercise (11) and repre-
sents a predictor for cardiac transplant and death (16).
It is known that diseases, such as Kawasaki’s disease (8),
hyperlipidemia (10), obesity, and type 1 diabetes, play im-
portant roles in systemic inflammation and endothelial dys-
function (17). These diseases may increase the likelihood of
cardiovascular events (18) and may predispose children to the
development of cardiomyopathy. Based on these considera-
tions, we reviewed the published literature on endothelial
function in pre-pubertal children to evaluate the endothelial
function in pre-pubertal children with cardiomyopathy or
children at risk of developing cardiomyopathy, and we
conducted an analysis of the data from the relevant studies.
This analysis was undertaken to help clarify the role of
endothelial impairment in children at risk of suffering from
cardiomyopathy.
Endothelial function can be analyzed by noninvasive
methods, including ultrasonography (US) (19) and periph-
eral artery tonometry (PAT) (20). During a US examination,
the baseline rest image of the subject’s brachial artery is
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acquired, and a 5-min arterial occlusion is performed using
cuff inflation to at least 50 mm Hg suprasystolic pressure.
The subsequent cuff deflation induces reactive hyperemia
that results in an increase in flow or, more precisely, shear
stress by dilating the brachial artery; this phenomenon is
designated flow-mediated dilatation (FMD). After returning
to the baseline, a second brachial artery image is recorded
after the administration of nitroglycerine (NTG); this image
corresponds to the contribution of the intima muscle
relaxation to the dilation and is known as the endothe-
lium-independent vasodilatation (19).
In contrast to US, the PAT evaluation is a method that
does not require the administration of drugs, and it
combines the assessment of the flow-mediated dilatation
after the same 5-min arterial cuff occlusion, with the arterial
pulse wave amplitude measurement taken using a pneu-
matic fingertip probe (20).
Literature search strategy
A search of the PubMed, Bireme, and SciELO databases
was conducted to perform a systematic review, according to
the recommendations of PRISMA (21). The search was
performed using the following keywords: endothelial, child,
pediatrics, and infant. The results were limited to human
studies published in English, Spanish, and Portuguese. The
initial selection was based on the title and abstract, and
those deemed relevant were retained for further analysis.
The exclusion criteria included the following: analyses of
the endothelial function in animals, cadavers, adolescents or
adults; reviews; analyses of either the coronary or pulmon-
ary arteries or the neurological or osteomuscular systems; if
the patients had rheumatic, oncohematological, splenic or
hepatic diseases; or if the studies were trials related to
markers, genetics and interventions.
The list of potential trials to include was verified by the
authors of the present study. We note that there may be a
risk of bias across the studies because not all of the trials
published have been indexed in the selected databases.
Collected data
The following data were collected for analysis: the
number of patients enrolled in the study; the patient’s age;
whether sexual maturity had been reached; any diseases
involved; the protocol used for the endothelial function
evaluation and the FMD, NTG, and PAT values. Collected
data in all tables were expressed following disease order, in
order to better clarify data presentation and analysis.
Statistical analysis
The values of endothelial function were expressed as the
mean ¡ standard deviation (SD), as collected from the
original trials. The data from healthy children were
compared with the data for unhealthy children, and the
differences were analyzed using the Student t-test. A p-
value ,0.05 was considered statistically significant.
A total of 559 articles were retrieved after the preliminary
search, and 21 articles were considered potentially relevant
based on the title and abstract. A careful analysis of these
articles was performed, and ten trials were excluded for
several reasons. Eleven articles were chosen for the final
analysis (Figure 1).
All of the selected studies were dated from 1996 to 2009.
Table 1 presents the general descriptions of the included
studies and provides information regarding the participants,
their ages, their diseases, the endothelial evaluation method
used and whether there were differences between genders
(Table 1).
All eleven of the selected studies provided data for healthy
children for comparison, and, with the exception of one study
(22), all of the studies compared healthy children to ill
children. Four of the studies evaluated obese children (23-26),
one evaluated children with obesity and type 1 diabetes (27),
three studied children with type 1 diabetes (28-30), and two
evaluated children with Kawasaki’s disease (31-32). No trial
involving children with cardiomyopathy was found.
These reviewed studies reported a mean age of 9.8¡1.8
years old, and only four articles investigated the sexual
maturation of the group of pre-pubertal children
(23,25,26,29). Forty-five percent of all of the studies found
no difference in the endothelial function between genders,
and 55% of the reports did not provide these data (Table 1).
Most of the studies used ultrasound to determine the
percent diameter changes for the FMD and NTG assess-
ments (22-29,31,32). Only one study used reactive hyper-
emia–peripheral artery tonometry (RH-PAT) for the same
purpose (30), showing that the endothelial function was
impaired in diabetic children relative to that in healthy
children (1.63¡0.5 vs. 1.95¡0.3 for diabetic children vs.
healthy children) (30).
The FMD response values from all of the other articles for
obese and diabetic children were significantly lower than
those for healthy children (5.9¡1.29% for obese children,
4.5¡0.7% for diabetic children, and 9.8¡1.8% for healthy
children; p,0.0008). The obese children had a 39% lower
FMD response than the healthy children, and the diabetic
children had a decrease in their FMD of 25% (Table 2).
The children with Kawasaki’s disease had 27% lower
FMD responses than the healthy children (7.1¡1.27% vs.
9.8¡1.8%, respectively), but this difference was not statis-
tically significant (p= 0.26). The FMD data for the obese
children, diabetic children, and children with Kawasaki’s
disease exhibited no statistically significant differences
(p,0.38) (Table 2).
Figure 1 - Search Strategy. Result of the literature search and the
selection of articles for analysis.
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The NTG response (Table 2) also showed no significant
difference among the groups (22.7¡7.1% for healthy
children, 19.6¡2.0% for obese children and 16.6¡5.9% for
diabetic children; p,0.19).
Among the excluded studies, one contained no data on
endothelial function (33), and most of the excluded studies
did not list the data for pre-pubertal children, post-pubertal
children (34-39) and adults (40,41) separately. Another
study (42) published data for the same patients as used in
a previously published study (32).
Ultrasound is the most frequently used method to evaluate
endothelial function because it has a low cost, is safe and is
sufficiently reproducible. However, some limitations of this
method are that the FMD response can be influenced by both
temperature and age, and ultrasound requires drug admin-
istration and the recording of images for posterior analysis
(19).
Another technique for the assessment of endothelial
function is the PAT method, which has been proposed to
be more practical and precise (20), and PAT results are
moderately significantly correlated with US results (43).
The PAT method combines the traditional flow-mediated
dilatation measurement with pneumatic fingertip probes
to measure the arterial pulse wave amplitude (20). One
study (31) chose PAT over US and confirmed that dia-
betic children have endothelial dysfunction, as do adults
(44,45).
In five studies (22,24,25,28,32), the gender of the indivi-
dual did not correlate with the endothelial function, as has
been found for adults (60) and adolescents (61). Pre-pubertal
children show lower responses to beta-adrenergic receptors
and have lower levels of circulating catecholamines (adrena-
line and noradrenaline) than adolescents and adults (46).
The obese children exhibit accelerated growth and, there-
fore, earlier puberty (47), which is evidenced by an
advancement of menarche by 2.2 years (11.2 vs. 13.4 years,
respectively) (48) because fat mass influences the levels of
hormones (49,50).
These data reinforce the need for the evaluation of sexual
maturation in studies involving children. The extent of
sexual maturation is widely accessed using the Tanner-
Whitehouse scale, which is based on secondary sexual
Table 1 - Study characteristics of the trials included in this review.
Study Year of publication N Age (years) PS Disease Method
Difference in
gender
Germain et al. (19) 2004 32 9.9 no none US no
Aggoun et al. (20) 2002 130 12.0 yes obesity US NI
Kapiotis et al. (21) 2006 92 12.0 no obesity US no
Aggoun et al. (22) 2008 71 8.8 yes obesity US no
Woo et al. (23) 2004 73 10.3 yes obesity US NI
Pena et al. (24) 2006 270 13.7 no obesity, diabetes US NI
Ja¨rvisalo et al. (25) 2004 75 11.0 no diabetes US no
Wiltshire et al. (26) 2006 55 13.7 yes diabetes US NI
Haller et al. (27) 2007 64 14.6 no diabetes PAT NI
Borzutzky et al. (28) 2008 22 10.2 no Kawasaki US no
Deng et al. (29) 2002 56 7.1 no Kawasaki US NI
PS, puberty state evaluated; Method, evaluation method of endothelial function; US, ultrasound; PAT, peripheral artery tonometry; NI, no data.
Table 2 - Percentage of endothelium-dependent vasodilatation (flow-mediated dilatation [FMD]) and percentage of
endothelium-independent vasodilatation after drug administration (NTG).
Study Mean FMD (%) in children Mean NTG (%) in children
healthy obese diabetic
Kawasaki’s
disease p-value healthy obese diabetic
Kawasaki’s
disease p-value
Germain et al.
(19)
10 NA NA NA NA NA NA NA NA NA
Aggoun et al.
(20)
8 6 NA NA 0.010 18 17 NA NA .0.05
Kapiotis et al.
(21)
11 7.7 NA NA 0.006 NA NA NA NA NA
Aggoun et al.
(22)
8.3 4.5 NA NA 0.001 25.8 19 NA NA .0.05
Woo et al. (23) 9.7 6.6 NA NA 0.001 19.6 20.6 NA NA .0.05
Pena et al. (24) 7.8 4.9 3.8 NA 0.001 27.7 21.7 20.5 NA 0.01
Ja¨rvisalo et al.
(25)
8.7 NA 4.4 NA 0.001 11.5 NA 9.7 NA .0.05
Wiltshire et al.
(26)
9.1 NA 5.2 NA 0.002 23.3 NA 19.5 NA .0.05
Borzutzky et al.
(28)
11.1 NA NA 8.0 .0.050 NA NA NA NA NA
Deng et al. (29) 14.1 NA NA 6.2 ,0.001 33.2 NA NA 30.6 .0.05
Mean¡SD 9.8¡1.8 5.9¡1.29 4.5¡0.7 7.1¡1.27 0.001* 22.7¡7.1 19.6¡2.0 16.6¡5.9 - .0.05{
p-value, data significance; NA, not applicable; NS, not significant; *p,0.0005, healthy vs. obese children; p,0.0008, healthy vs. diabetic children; {p,0.11,
healthy vs. obese children; p,0.19, healthy vs. diabetic children.
CLINICS 2012;67(3):273-278 Endothelial function in pre-pubertal children
Tavares AC et al.
275
characteristics, such as breast development and menarche in
girls, standards for penis development in boys, and pubic
hair development in both sexes (51). This lack of sexual
maturity assessment explains why those trials that combined
information for children, adolescents (33-39), and adults
(40,41) were excluded in the present study and explains the
elevated FMD data from one study (24), which included a
higher mean age of obese children of 12¡4 years old. The
evaluation of sexual maturity also explains why three of the
included studies (23,25,26) that assessed the pubertal stage by
clinical examination yielded similar FMD data.
Diabetic and obese individuals have hyperinsulinemia,
and both diabetes and obesity are related to the higher
hormone (50) and inflammation levels (52) that contribute to
increased arterial stiffness and vascular lesions, which are
related to both endothelial function and structural arterial
changes (53) and may explain the endothelial dysfunction
results for these groups (23-30).
In addition to some methodological disparities, all of the
studies showed significantly impaired endothelial function
(FMD response) in the obese and diabetic children despite
the lack of a difference in the NTG response, a result that
was reported for adults (54) when compared with healthy
subjects (55). However, FMD impairment seems to be
greater in adults than in children (44% in obese adults and
55% in diabetic adults); similarly, adults show no difference
in NTG responses (54,56).
The collected FMD values in children with Kawasaki’s
disease are lower than those in healthy children (31,32),
which can indicate a low, but persistent, level of inflamma-
tion (57), as evidenced by higher C-reactive protein (CRP)
levels (52,53,58). Only one study (32) included NTG data,
and this lack of data limits the discussion of the information
provided.
The FMD values suggest that the major dysfunctions in
these children occur as a result of the local nitric oxide (NO)
bioavailability in the endothelium (NO production) because
the shear stress induced by reactive hyperemia activates
endothelial NO production (59).
The NTG response also suggests that the vascular smooth
muscle cell function is preserved (19). Yet, one study
showed significantly lower GT values in obese children
than in healthy children (27), and two other studies did not
publish values for the NTG response (22,24). Some reports
(20,25,28) did not describe how long the subjects were at
rest, according to Corretti et al. (22), .10 min is recom-
mended, between the collections of the FMD and NTG
response images, which might have contributed to the
reported outcomes. It is also worth noting that three of the
trials (24,27,29) allowed the arteries to return to the basal
condition and that two of these studies (24,29) did not yield
statistically significant data.
Limitations
In spite of the statistically significant differences in some
of the endothelial function responses, the number of trials
regarding this subject remains limited. Another limitation of
the data search for pre-pubertal children is that the studies
list the results for adults, teenagers, and children together,
and do not divide the data by group according to the
puberty state and age. The small number of studies in
children may also be due to the use of the US method
because drug administration is required. However, the new
method of endothelial function evaluation, the PAT method,
might help increase the number of trials using this
population.
Although endothelial dysfunction has been identified in
adults as a predictor of cardiac transplant and death, the
clinical implications of endothelial dysfunction were not
presented in the selected trials, nor were they the focus
of the current study; however, this correlation should
be further evaluated in children. Lastly, even though the
number of pre-pubertal children with endothelial dysfunc-
tion is unknown, there is a great number of children who
suffer from this condition. Thus, the barriers in the pediatric
field must be broken, and more studies on this topic should
be performed to understand this population better.
In conclusion, endothelial function is an important clinical
feature because it may indicate the severity of cardiovas-
cular symptoms, prognosis, and mortality. Children at risk
of developing cardiomyopathy exhibit endothelial dysfunc-
tion; however, the prevalence of endothelial dysfunction in
cardiomyopathic children remains unknown because of the
lack of data. We suggest that attention should be paid to the
consequences of endothelial function in this group.
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